Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of structure-based drug design to create or improve modulators of IL-1 activity which bind to the interleukin-1 type 1 receptor

Method of structure-based drug design to create or improve modulators of IL-1 activity which bind to the interleukin-1 type 1 receptor

US Patent 7144988 · Granted Dec 5, 2006

Estimated economic value: $2,330,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fl2025
Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fl2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
KRas G12D inhibitors2024
KRas G12C inhibitors2024
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors2023
KRas G12D inhibitors2022
KRAS G12C inhibitors2022
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2021
Point mutations in TRK inhibitor-resistant cancer and methods relating to the sa2021
Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the t2021
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors2021